Comparative Study of Two Recombinant Human Erythropoietin Products in Chronic Kidney Disease Patients
Phase 3
Not yet recruiting
- Conditions
- Anemia of Chronic Kidney Disease
- First Posted Date
- 2024-04-08
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Megalabs
- Target Recruit Count
- 280
- Registration Number
- NCT06352138
- Locations
- 🇺🇾
Megalabs, Colonia Nicolich, Canelones, Uruguay
Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Megalabs
- Target Recruit Count
- 24
- Registration Number
- NCT06331715
- Locations
- 🇮🇳
Azidus Laboratories, Chennai, India
A Pilot Bioequivalence Study of Pomalidomide
Phase 1
Not yet recruiting
- Conditions
- Bioequivalence Study
- Interventions
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Megalabs
- Target Recruit Count
- 10
- Registration Number
- NCT06058689
- Locations
- 🇮🇳
Azidus Laboratories, Chennai, Tamil Nadu, India
Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers
Phase 1
Not yet recruiting
- Conditions
- Healthy
- Interventions
- Biological: Filgrastim MegalabsBiological: Granulokine
- First Posted Date
- 2021-07-12
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Megalabs
- Target Recruit Count
- 100
- Registration Number
- NCT04958772
Biosimilarity Study of Intravenous Recombinant Human Erythropoietin in Healthy Volunteers
Phase 1
Not yet recruiting
- Conditions
- Healthy
- Interventions
- Biological: Experimental Erythropoietin subcutaneous injection single dose of 4,000 IUBiological: Active comparator Erythropoietin subcutaneous injection single dose of 4,000 IU
- First Posted Date
- 2021-07-08
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Megalabs
- Target Recruit Count
- 52
- Registration Number
- NCT04954989
- Locations
- 🇮🇳
Azidus Laboratories, Chennai, India
Biosimilarity Study of Subcutaneous Pegfilgrastim in Healthy Volunteers
Phase 1
Completed
- Conditions
- Neutropenia
- Interventions
- Biological: Pegfilgastrim MegalabsBiological: Pegfilgastim Amgen
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Megalabs
- Target Recruit Count
- 72
- Registration Number
- NCT04873765
- Locations
- 🇺🇾
Marcos Giusti, Montevideo, Uruguay
© Copyright 2025. All Rights Reserved by MedPath